Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Neurotrophic factor receptors" refer collectively to cell-surface proteins that mediate the effects of neurotrophic factors, including the Trk family of receptor tyrosine kinases (TrkA/NTRK1, TrkB/NTRK2, TrkC/NTRK3) and the p75 neurotrophin receptor (p75NTR, NGFR), as well as receptors for other neurotrophic factors such as GDNF family ligands (RET, GFRα1-4). These receptors regulate key processes in neural development, survival, maintenance, differentiation, and plasticity, and are implicated in neurodegenerative diseases, psychiatric disorders, nerve injury, and some cancers. Due to the diversity of individual receptors in this group, precise functional, pathologic, and pharmacologic information depends on the specific receptor subtype involved.
Receptor agonism (mimicking neurotrophic factors); Receptor antagonism (inhibition of Trk signaling in cancer); Modulation of signal transduction pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotrophic factor receptors.